Aytu biopharma announces pricing of public offering

Englewood, co / accesswire / august 9, 2022 / aytu biopharma, inc. (the "company" or "aytu") (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the pricing of its underwritten public offering of (i) 21,505,814 shares of its common stock, and, in lieu of common stock to certain investors that so chose, pre-funded warrants to purchase 1,750,000 shares of its common stock, and (ii) accompanying warrants (the "common warrants") to purchase 23,255,814 shares of its common stock (the "offering"). the shares of common stock (or pre-funded warrants) and the accompanying common warrants will be issued separately but can only be purchased together in this offering.
AYTU Ratings Summary
AYTU Quant Ranking